Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to 0.13%.

  • Haemonetics' Return on Capital Employed rose 500.0% to 0.13% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.13%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.13% for FY2025, which is 300.0% up from last year.
  • According to the latest figures from Q4 2025, Haemonetics' Return on Capital Employed is 0.13%, which was up 500.0% from 0.13% recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Return on Capital Employed peaked at 0.13% during Q4 2025, and registered a low of 0.03% during Q1 2022.
  • Its 5-year average for Return on Capital Employed is 0.08%, with a median of 0.08% in 2022.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -1000bps in 2021, then skyrocketed by 600bps in 2022.
  • Quarter analysis of 5 years shows Haemonetics' Return on Capital Employed stood at 0.03% in 2021, then soared by 185bps to 0.09% in 2022, then grew by 8bps to 0.09% in 2023, then fell by -14bps to 0.08% in 2024, then skyrocketed by 64bps to 0.13% in 2025.
  • Its Return on Capital Employed was 0.13% in Q4 2025, compared to 0.13% in Q3 2025 and 0.12% in Q2 2025.